Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Insight Molecular Diagnostics (IMDX) Current Assets (2020 - 2025)

Historic Current Assets for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to $21.4 million.

  • Insight Molecular Diagnostics' Current Assets rose 34625.5% to $21.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.4 million, marking a year-over-year increase of 34625.5%. This contributed to the annual value of $11.8 million for FY2024, which is 991.77% up from last year.
  • As of Q3 2025, Insight Molecular Diagnostics' Current Assets stood at $21.4 million, which was up 34625.5% from $26.8 million recorded in Q2 2025.
  • In the past 5 years, Insight Molecular Diagnostics' Current Assets ranged from a high of $62.8 million in Q1 2021 and a low of $4.8 million during Q3 2024
  • Over the past 5 years, Insight Molecular Diagnostics' median Current Assets value was $24.6 million (recorded in 2022), while the average stood at $26.6 million.
  • Its Current Assets has fluctuated over the past 5 years, first tumbled by 7166.76% in 2024, then soared by 45490.44% in 2025.
  • Over the past 5 years, Insight Molecular Diagnostics' Current Assets (Quarter) stood at $39.1 million in 2021, then tumbled by 34.76% to $25.5 million in 2022, then plummeted by 58.11% to $10.7 million in 2023, then increased by 9.92% to $11.8 million in 2024, then skyrocketed by 81.89% to $21.4 million in 2025.
  • Its Current Assets was $21.4 million in Q3 2025, compared to $26.8 million in Q2 2025 and $36.3 million in Q1 2025.